Premium
A double‐blind trial of 0.05% clobetasol proprionate in the treatment of vitiligo
Author(s) -
CLAYTON ROGER
Publication year - 1977
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1977.tb05188.x
Subject(s) - vitiligo , medicine , dermatology
SUMMARY 0.05% clobetasol proprionate (CP) in its proprietary cream base was significantly superior to the cream base alone in the treatment of vitiligo. Twelve of twenty‐three patients partially repigmented during 4 months' treatment with CP. All patients showed dermal atrophy with the CP.